- Open Access
Correction to: USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health
Globalization and Health volume 15, Article number: 44 (2019)
- The original article was published in Globalization and Health 2019 15:35
Correction to: Globalization and Health (2019) 15:35.
Following publication of the original article , the authors flagged an error concerning two missing article references, which were unfortunately not provided prior to publication of the article.
The two missing references are:
Lexchin, J. (2019) Increase in drug spending in Canada due to extension of data protection for biologics: a descriptive study. Healthcare Policy 14 (3) 10–18.doi:https://doi.org/10.12927/hcpol.2019.25796
This should be referenced under the sub-heading ‘Pharmaceuticals and access to medicines’ in place of the first two (under this sub-heading) references to reference ‘9’.
O’Brien P, Gleeson D, Room R, Wilkinson C. Marginalising health information: implications of the Trans Pacific Partnership for alcohol labelling. Melbourne University Law Review. 2017;41(1):341–91.
This should be referenced under the sub-heading ‘Agriculture’ in place of the second (under this sub-heading) reference to reference ‘30’.
The authors apologize for this error.
Labonté et al. (2019) USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health (2019) 15:35 DOI: https://doi.org/10.1186/s12992-019-0476-8
About this article
Cite this article
Labonté, R., Crosbie, E., Gleeson, D. et al. Correction to: USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health. Global Health 15, 44 (2019). https://doi.org/10.1186/s12992-019-0482-x